Description: Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
Home Page: www.embecta.com
EMBC Technical Analysis
300 Kimball Drive
Parsippany,
NJ
07054
United States
Phone:
201 847 6880
Officers
| Name | Title |
|---|---|
| Mr. Devdatt Kurdikar | Pres, CEO & Director |
| Mr. Jacob P. Elguicze | Sr. VP & CFO |
| Mr. Jeffrey Z. Mann | Sr. VP, Gen. Counsel, Head of Corp. Devel. & Corp. Sec. |
| Mr. Ajay Kumar | Sr. VP & Chief HR Officer |
| Mr. Shaun Curtis | Sr. VP of Global Manufacturing & Supply Chain |
| Mr. Brian R. Capone | VP, Chief Accounting Officer & Corp. Controller |
| Ms. Colleen Riley | Sr. VP & Chief Technology Officer |
| Ms. Ginny Blocki | Sr. VP of Global Marketing & Product Management |
| Mr. Tom Blount | Sr. VP & Pres of North America |
| Mr. Slobodan Radumilo | Sr. VP & Pres of International |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 6.317 |
| Price-to-Book MRQ: | 2.6134 |
| Price-to-Sales TTM: | 1.6539 |
| IPO Date: | 2022-04-01 |
| Fiscal Year End: | September |
| Full Time Employees: | 1900 |